CNS Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/14/2022 | 453,615 | $81,000 | 6.06% | 1.13% |
| BANK OF NEW YORK MELLON CORP | 11/14/2022 | 203,548 | $36,000 | 0.00% | 0.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/14/2022 | 129,016 | $23,000 | 0.00% | 0.32% |
| VIRTU FINANCIAL LLC | 11/07/2022 | 127,922 | $23,000 | -28.21% | 0.32% |
| TWO SIGMA SECURITIES, LLC | 11/14/2022 | 90,487 | $16,000 | 100.00% | 0.23% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2022 | 56,800 | $10,000 | 100.00% | 0.14% |
| FSM WEALTH ADVISORS, LLC | 10/24/2022 | 40,000 | $7,000 | 0.00% | 0.10% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/10/2022 | 34,526 | $6,000 | 19.03% | 0.09% |
| NORTHERN TRUST CORP | 11/14/2022 | 32,094 | $6,000 | 0.00% | 0.08% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/17/2022 | 25,250 | $5,000 | 0.00% | 0.06% |
| STATE STREET CORP | 11/15/2022 | 19,645 | $4,000 | 0.00% | 0.05% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 18,549 | $3,000 | 100.00% | 0.05% |
| HIGHTOWER ADVISORS, LLC | 11/09/2022 | 18,000 | $3,000 | 12.50% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/14/2022 | 12,210 | $2,000 | 0.11% | 0.03% |
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | 11/08/2022 | 10,727 | $2,000 | 0.00% | 0.03% |
| ALPHA CUBED INVESTMENTS, LLC | 11/04/2022 | 10,000 | $2,000 | 0.00% | 0.03% |
| GLOBAL RETIREMENT PARTNERS, LLC | 11/03/2022 | 1,000 | $0 | 0.00% | 0.00% |
| GRADIENT INVESTMENTS LLC | 10/14/2022 | 200 | $0 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2022 | 177 | $0 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2022 | 10 | $0 | 0.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 11/15/2022 | 0 | $0 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2022 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISERS, LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
CNS Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of CNS Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Urban Wealth Management, LLC: 100
SHINE INVESTMENT ADVISORY SERVICES INC: 30
3.20% of CNS Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 130 shares in the last 24 months. This purchase volume represents approximately $14 in transactions.